Cell Death and Differentiation Response to Reviewers: How to Write a Rebuttal That Wins (2026)
How to write a point-by-point response to reviewers for Cell Death and Differentiation, where a major revision means new mechanism data and genetic or in-vivo validation, not a second round of marker stains.
Readiness scan
Before you submit to Cell Death and Differentiation, pressure-test the manuscript.
Run the Free Readiness Scan to catch the issues most likely to stop the paper before peer review.
Cell Death and Differentiation at a glance
Key metrics to place the journal before deciding whether it fits your manuscript and career goals.
What makes this journal worth targeting
- IF 15.4 puts Cell Death and Differentiation in a visible tier — citations from papers here carry real weight.
- Scope specificity matters more than impact factor for most manuscript decisions.
- Acceptance rate of ~Selective Springer Nature cell-death journal means fit determines most outcomes.
When to look elsewhere
- When your paper sits at the edge of the journal's stated scope — borderline fit rarely improves after submission.
- If timeline matters: Cell Death and Differentiation takes ~Editorial screening first. A faster-turnaround journal may suit a grant or job deadline better.
- If open access is required by your funder, verify the journal's OA agreements before submitting.
How to use this page well
These pages work best when they behave like tools, not essays. Use the quick structure first, then apply it to the exact journal and manuscript situation.
Question | What to do |
|---|---|
Use this page for | Building a point-by-point response that is easy for reviewers and editors to trust. |
Start with | State the reviewer concern clearly, then pair each response with the exact evidence or revision. |
Common mistake | Sounding defensive or abstract instead of specific about what changed. |
Best next step | Turn the response into a visible checklist or matrix before you finalize the letter. |
Quick answer: A Cell Death and Differentiation response to reviewers is an editor-led, point-by-point rebuttal where a major revision means new mechanism data, not a wording pass. At this mechanism-first journal, treat a revision as a request for the genetic or in-vivo validation and the mode-of-death assays that prove the death program you claim is causal.
Open with a short letter to the handling editor, give the exact page and line number you cite for every change, answer under Reviewer 1, 2, and so on, and resubmit through Springer Nature Editorial Manager with a separate point-by-point file.
Start with the Cell Death and Differentiation rebuttal readiness check before you resubmit, or work through this guide by hand. For broader cluster context, see the Cell Death and Differentiation journal overview.
What does a Cell Death and Differentiation response to reviewers require?
The Manusights Cell Death and Differentiation rebuttal scan. This guide tells you what the handling editor and the referees look for in a CDD rebuttal. The scan tells you whether YOUR response letter passes that check before you resubmit through Springer Nature Editorial Manager. We have reviewed manuscripts and rebuttals targeting Cell Death and Differentiation and adjacent Nature Portfolio cell-death venues; the patterns below are the same ones referees flag at re-review. We do not train AI on your manuscript and delete it within 24 hours.
Three things make a Cell Death and Differentiation rebuttal different from a generic one.
First, it is editor-led: the handling editor integrates the referee reports and decides what a revision must contain, so your letter to the editor matters as much as the per-reviewer replies.
Second, the journal is mechanism-first, so a major revision almost always means new functional data, a genetic or in-vivo confirmation, or a mode-of-death assay rather than clarification.
Third, the revised version is normally sent back to some or all original referees, and the paper can still be rejected after re-review.
Our methodology for this guide: we read Cell Death and Differentiation's own editorial-process and Guide to Authors documentation, checked it against the Nature Portfolio peer-review policy and the Nomenclature Committee on Cell Death (NCCD) recommendations the journal itself published, and compared it to our own pre-submission reviews of CDD-targeted rebuttals, so every claim below traces to a primary source or our review corpus.
Use this guide to pressure-test your response letter before you resubmit the revision, because at a selective mechanism-first journal a thin rebuttal can turn a major revision into a rejection.
Element | What Cell Death and Differentiation expects | What referees flag at re-review |
|---|---|---|
Structure | Editor letter, then point-by-point under Reviewer 1, 2, and beyond | Free-form prose answering all comments together |
New data | New mechanism experiments, genetic or in-vivo validation | "We have clarified this in the text" with no new figure |
Mode of death | Assays that distinguish the death program you claim | More viability or marker stains that do not prove the mode |
Specificity | Page and line number for every manuscript change | "We have updated the manuscript" with no location |
Tone | Substantive on mechanism, gracious on style | Defensive on every minor stylistic suggestion |
Consistency | Same answer to the same point across all referees | Different framing for Reviewer 1 vs Reviewer 3 |
Source: Cell Death and Differentiation editorial-process and Guide to Authors documentation, Nature Portfolio peer-review policy, accessed June 2026.
The copyable Cell Death and Differentiation rebuttal template
Referees at Cell Death and Differentiation re-read the manuscript against your replies, so a clean, scannable structure is doing real work. Copy this skeleton, then replace the bracketed text with your own changes. Keep the reviewer text and your reply in two distinct fonts or colors.
Dear Editor,
Thank you for the opportunity to revise our manuscript the manuscript title
(CDD-[ID]). We are grateful to the referees for their careful
reports. In response, we have added the genetic loss-of-function
experiment requested (new Figure 3), an in-vivo confirmation in
[model] (new Figure 5), and the mode-of-death assays that
distinguish [apoptosis / necroptosis / pyroptosis / ferroptosis]
from the alternatives. A point-by-point response follows; reviewer
comments are in bold and our replies in plain text, with
revised-manuscript page and line numbers given for every change.
----------------------------------------------------------------
Reviewer 1
Comment 1.1: "The authors claim ferroptosis but show only a
viability drop rescued by ferrostatin-1."
Response: We agree the original evidence was insufficient. We have
added the genetic test (GPX4 and ACSL4 knockdown, new Figure 3b)
and a lipid-peroxidation readout (C11-BODIPY, new Figure 3c), and
confirmed iron dependence with deferoxamine. The death mode is now
established by three orthogonal criteria. See page 8, lines 4 to 19.
Comment 1.2: "The mechanism is correlative; there is no causal
loss-of-function."
Response: We have added a [knockout / shRNA / CRISPR] experiment
showing the phenotype is lost when [gene] is removed and rescued by
re-expression (new Figure 4a-c). Changed text is on page 11,
lines 2 to 14.
----------------------------------------------------------------
Reviewer 2
Comment 2.1: "The in-vitro result is not validated in vivo."
Response: We have added an in-vivo confirmation in [mouse model /
genetic cross] (new Figure 5a-d) showing the same dependence on
[pathway]. See page 14, lines 6 to 22, and Supplementary Figure 7.
Comment 2.2: "The statistics for the survival analysis are unclear."
Response: We have clarified n = [N] per group, added the test used,
and reported the exact p-value in the legend. See page 17,
lines 1 to 8, and Supplementary Table 3.
We believe the revised manuscript now establishes the causal
mechanism and the death mode, and we look forward to your decision.
Sincerely,
[Corresponding author, on behalf of all authors]The template carries the four tokens referees actually scan for: a letter to the editor, a Reviewer 1 / 2 structure, explicit action language ("we have added", "we have confirmed", "we have clarified"), and a page and line reference for every change.
The page-and-line rule: cite the location of every change
State the exact page and line number for each manuscript revision, and reference the specific figure, table, or supplementary file you changed. This is the single most-cited rebuttal failure at Cell Death and Differentiation and across the Nature Portfolio.
A referee who has to hunt for your change reads it as evasion. A referee who can click straight to page 8, lines 4 to 19, and see the new GPX4 knockdown finishes faster and re-reviews more favorably. Never write "we have addressed this in the manuscript" without a location. Use the line numbers from the revised file, not the original, and note when a change is in a Supplementary figure rather than the main text.
Reviewer-text vs author-response typography
Make the referee's words and your reply visually distinct. Put each reviewer comment in bold or a colored text box, and keep your response in plain regular text directly beneath it.
The handling editor and the referees scan dozens of these letters. A rebuttal where comment and reply blur together costs you attention you need. At a journal where revisions normally go back to some or all original referees, a clean two-font or two-color layout lets a referee verify in minutes that the specific experiment they asked for is now there.
Tone calibration: how to phrase the hard replies
The referees see your tone across every comment, and the editor reads all of it. A defensive reply to Reviewer 1 is visible to the editor deciding whether to accept. Calibrate. The pattern at Cell Death and Differentiation is specific: concede where the mechanism evidence was thin, do the experiment, and push back only on a request that is genuinely out of scope, with a reason and an alternative.
Bad (defensive or vague) | Better (substantive and mechanism-first) |
|---|---|
"The reviewer has misunderstood our cell-death data." | "We did not present the data clearly; we have added the genetic loss-of-function test (new Figure 4) that makes the mechanism causal, page 11, lines 2 to 14." |
"The death mode is obvious from the morphology." | "We agree morphology alone is not sufficient. We have added caspase-dependence and the gasdermin-cleavage western (new Figure 3d) to establish pyroptosis specifically. See page 9, lines 5 to 16." |
"An in-vivo experiment is outside the scope of this paper." | "We agree this would strengthen the work and have added an in-vivo confirmation (new Figure 5). Where a full model was not feasible, we used [alternative] and noted the limit in the Discussion." |
"We have addressed this concern." | "We have added the requested ACSL4-knockdown control (new Figure 3b, page 8, lines 4 to 11)." |
"Our result is obviously correct." | "We have added the statistical test the referee requested (Methods, page 17); the effect remains significant (p = [value])." |
The pattern that works: concede where the referee is right, run the experiment that proves the mechanism, point to the exact change, and reserve pushback for the genuinely impossible request.
The Cell Death and Differentiation reviewer culture you are writing into
Cell Death and Differentiation is editor-led: a handling editor owns the decision and decides what a revision must demonstrate. Manuscripts sent for review are evaluated by at least one independent referee, usually two or more, and referees are not identified to authors unless a referee chooses to sign.
Authors may suggest referees, but the choice is at the editor's discretion. The defining feature for your rebuttal is the mechanism-depth bar: this is a specialist cell-death journal whose readers already know apoptosis, autophagy, necroptosis, pyroptosis, and ferroptosis, so a revision that adds description without causal proof does not move the decision.
The revision mechanics are concrete. The editor invites a revision when the referees' concerns can be addressed in six months or less, which is your planning clock. When submitting a revision, authors are asked to upload three files: a rebuttal letter, a marked-up manuscript, and a clean manuscript.
The revised version is normally sent back to some or all of the original referees for re-review. The revised Article still has to fit CDD's limits, an abstract of up to 300 words and a main text of around 3,500 words, so a revision that adds three new figures often means cutting prose elsewhere.
The practical consequence: a major revision is real experimental work, returned within the editor's window, documented precisely.
The substance that separates a CDD revision from a generic one is the mode-of-death rigor the journal itself codified. Cell Death and Differentiation published the Nomenclature Committee on Cell Death (NCCD) recommendations (Galluzzi et al., 2018; doi 10.1038/s41418-017-0012-4), which set the bar that morphology and a single rescue compound are not enough to claim a death mode.
The community assay guidelines (doi 10.3389/fcell.2021.634690) ask for the same multiparametric, genetic confirmation: ferroptosis needs lipid-peroxidation readouts plus GPX4 or ACSL4 dependence and iron-chelation rescue; pyroptosis needs caspase-1/4/5/11 dependence and gasdermin cleavage; necroptosis needs RIPK3 or MLKL dependence. When a referee says "you have not shown this is ferroptosis," they are invoking this standard. Your rebuttal has to meet it with new experiments, not with more markers.
How this compares to the rest of the field matters for calibration. A response to reviewers at the sibling journal Cell Death & Disease can lead with a translational angle when the mechanism is solid, while at Cell Death and Differentiation the mechanism-depth is the protagonist and the genetic and in-vivo confirmation is the price of acceptance.
At a broad-scope venue like Nature Communications the bar is broad significance with new experiments; at CDD it is narrower and deeper, the causal cell-death program proven by orthogonal genetic and pharmacological evidence. Calibrate your rebuttal to depth, not breadth.
Key Insight
At Cell Death and Differentiation, a major revision is a request for the genetic and in-vivo confirmation of the death mode you claim, not a request to rewrite the Discussion. If a referee questions the mode of death, no amount of additional marker staining answers them; only the assays that distinguish the mode do.
What our Cell Death and Differentiation rebuttal reviews surface
In our pre-submission review work with Cell Death and Differentiation manuscripts, the rebuttals that stall in a second revision round share a small set of recurring weaknesses. These are the same ones referees flag at re-review, and each maps to a specific, named failure pattern in the journal's mechanism-first editorial culture. In practice, the rebuttals that clear one round and the ones that stall differ on exactly these points. Each is testable against your own draft response before you resubmit.
Answering a mechanism request with more markers or expression data. The most common and most expensive pattern in our Cell Death and Differentiation pre-submission reviews is a rebuttal that answers a request for causal mechanism with another round of marker staining or qPCR.
A referee who asks whether the death program is causal is asking for a genetic loss-of-function and rescue, not a higher-resolution correlation. When a reviewer questions whether the result is causal, adding a fourth marker does not move the decision; adding the knockout or knockdown experiment does. Across our CDD rebuttal reviews, this mismatch between what the referee requested and what the author delivered is the single strongest predictor of a third round.
Mode-of-death confusion left unresolved. Because Cell Death and Differentiation set the NCCD standard, a referee who doubts the death mode will not accept morphology or a single inhibitor. In our CDD pre-submission reviews we see a paper that claims ferroptosis but shows only a ferrostatin-1 rescue, or claims pyroptosis without caspase dependence and gasdermin cleavage. CDD referees routinely reject this until the orthogonal evidence is added.
The rebuttal that resolves this adds the orthogonal genetic and pharmacological criteria the committee requires; the rebuttal that restates the original claim draws the same comment a second time and a likely rejection.
Missing the in-vivo or genetic confirmation the reviewer asked for. A rebuttal that promises an in-vivo experiment "in future work" reads as a concession that the mechanism is not yet proven. In our pre-submission review work with Cell Death and Differentiation manuscripts, responses that skip the in-vivo or genetic validation a referee explicitly requested consistently draw a re-review comment that the central claim is still unsupported.
If the model is genuinely infeasible, say so with a reason and substitute the strongest available genetic evidence, rather than leaving the gap silent.
Generic acknowledgment without a page or line number. A rebuttal that says "we have revised the manuscript accordingly" forces the referee to hunt for the change in a long revised file with new figures and supplementary data. In our Cell Death and Differentiation reviews, responses that omit the location of each figure, table, or text change consistently draw a re-review comment asking where the change is, which adds a round. Every reply needs the page and line number of the revised file.
Run the new mechanism data, prove the death mode, add the in-vivo or genetic confirmation, and document the location. That four-part discipline is what separates a Cell Death and Differentiation rebuttal that clears one revision round from one that stalls into a second or third. Check your Cell Death and Differentiation point-by-point response for these patterns before you resubmit.
Readiness check
Run the scan while Cell Death and Differentiation's requirements are in front of you.
See how this manuscript scores against Cell Death and Differentiation's requirements before you submit.
When to comply and when to push back
Situation | Recommended approach at Cell Death and Differentiation |
|---|---|
Referee requests a genetic loss-of-function for the mechanism | Comply. This is the highest-leverage fix; run the knockout or knockdown and the rescue. |
Referee doubts the death mode you claim | Comply. Add the orthogonal NCCD criteria (genetic dependence plus a specific biochemical readout). |
Referee requests an in-vivo experiment that is genuinely infeasible | Push back with a reason, add the strongest genetic evidence available, note the limit in the Discussion. |
Referee questions sample size or statistics | Comply. Add the test, the exact p-value, and n per group to the legend and Methods. |
Referee asks for more markers when the mechanism is the real gap | Reframe. Add the causal experiment, not the marker, and explain why it answers the underlying concern. |
Referee raises a point a co-author disputes | Engage substantively, defend with new data, accept refinements. The editor reads every reply. |
Source: Manusights pre-submission reviews of Cell Death and Differentiation-targeted resubmissions, 2025 cohort.
How much work a Cell Death and Differentiation rebuttal actually takes
Authors consistently underestimate the new-experiment effort and overestimate the writing effort. This breakdown is about workload, not the journal's decision clock; for the end-to-end decision schedule, see the Cell Death and Differentiation submission guide.
Rebuttal task | Where the effort goes | What it costs you |
|---|---|---|
Reading and clustering referee reports | Finding the one mechanism concern behind the comments | A day of careful reading, not a skim |
Running genetic and in-vivo experiments | The actual bar for a major revision at a mechanism-first journal | The bulk of the work, often the full six-month window |
Adding the mode-of-death assays | Proving the death program with orthogonal NCCD criteria | Underestimated most often, and referees notice |
Writing the point-by-point replies | One reply plus a page and line reference per comment | Less than authors fear once the data exist |
Reconciling overlapping comments | Same answer for every referee who raised a point | Skipped most often, and it shows |
Source: Manusights pre-submission reviews of Cell Death and Differentiation resubmissions, 2025 cohort, last updated June 7, 2026.
Honest friction: rejection on revision is real
A major-revision invitation at Cell Death and Differentiation is not a soft acceptance. The revised version is normally sent back to some or all of the original referees, and the paper can still end in rejection after re-review if the new data do not establish the death mode or the causal mechanism.
At a selective mechanism-first journal, editors do not rubber-stamp revisions. Most rejections at this stage trace to one cause: the author answered a request for new mechanism experiments with more markers or with text. The second most common is mode-of-death confusion that the new experiments did not resolve.
Think twice before you resubmit if any of these are true. The response uses generic "we have addressed this" language with no page or line numbers. A referee asked for a genetic or in-vivo confirmation and you answered with expression data. You claim a specific death mode but still show only morphology and a single inhibitor. The same comment from two referees got two different answers. Fixing these before resubmission is what keeps a second round from becoming a rejection.
Red flags a Cell Death and Differentiation referee spots in seconds
Before you resubmit, scan your own rebuttal for the patterns that draw an immediate re-review comment. Each is a specific, checkable thing in your draft, not a vague quality dimension.
- A mechanism request answered with markers. A referee asked whether the death program is causal and the reply only adds another stain or qPCR panel. This is the single most common cause of a third round at a mechanism-first journal.
- A death-mode claim with no genetic confirmation. You call it ferroptosis, pyroptosis, or necroptosis but show no GPX4/ACSL4, caspase, or RIPK3/MLKL dependence.
The NCCD standard the journal itself published is not met.
- An in-vivo gap deferred to "future work." A reviewer asked for in-vivo or genetic validation and the reply promises it later. The editor reads this as the central claim still unproven.
- A reply with no location. Any "we have revised the manuscript" with no page and line number reads as evasion the moment a referee cannot find the change.
How does this guide go beyond the Cell Death and Differentiation author guidelines?
The official Guide to Authors and editorial-process page tell you to submit a point-by-point rebuttal letter, a marked-up manuscript, and a clean manuscript, and they explain that revision is used when concerns can be addressed in six months or less. The broader craft of the rebuttal is covered well by upstream sources like the PLOS Computational Biology "Ten simple rules for writing a response to reviewers" and the 2025 Nature Computational Science editorial on responding to reviewers, but neither is journal-specific.
What they do not tell you is that a major revision at this journal usually means genetic and in-vivo confirmation of the death mode, that referees apply the NCCD mode-of-death standard the journal published, or that answering a mechanism request with more markers is the leading cause of rejection on revision. Those facts change how you write every reply. The patterns above come from our pre-submission reviews of Cell Death and Differentiation rebuttals, and they are testable against your own draft today, not theoretical concerns.
- Manusights pre-submission reviews of Cell Death and Differentiation-targeted manuscripts (2025 cohort)
Frequently asked questions
Open with a short letter to the handling editor summarizing the new mechanism data you added. Then answer each comment in order under Reviewer 1, Reviewer 2, and any further reviewers, quote the referee text in full, state the exact change you made, and give the page and line number in the revised manuscript. Submit a rebuttal letter, a marked-up manuscript, and a clean manuscript through the revision link in your decision letter.
For a major revision, usually yes. The editor invites a revision when the referees' concerns can be addressed in six months or less, and at a mechanism-first journal those concerns are almost always for new functional data, a genetic or in-vivo confirmation, or an assay that proves the death mode you claim. Answering a mechanism request with more markers or expression data is the most common reason a rebuttal stalls into a second round.
The editor sets a revision deadline based on how long the work should take, and CDD invites a revision when the concerns can be addressed in six months or less. Minor revisions get a shorter window. Ask the editor for an extension before the deadline if a new in-vivo experiment or genetic cross needs more time, rather than returning a thin revision on time.
Yes. A major-revision invitation is not an acceptance. The revised version is normally sent back to some or all of the original referees, and the paper can be rejected after re-review if the new data do not establish the death mode or the causal mechanism. The most common rejection on revision traces to mode-of-death confusion that the new experiments did not resolve.
Cell Death and Differentiation wants the basic death or differentiation mechanism to be the protagonist, so reviewers push for genetic and in-vivo confirmation of the mechanism. The sibling journal Cell Death & Disease accepts disease-applied work where the mechanism is solid but the translational angle leads. If your reviewers are asking mainly for clinical relevance rather than mechanism, you may be writing into a Cell Death & Disease revision, not a CDD one.
Sources
- Editorial process, Cell Death & Differentiation (accessed June 2026)
- Guide to Authors, Cell Death & Differentiation (accessed June 2026)
- How to publish your paper, Nature Portfolio (revision and point-by-point response policy) (accessed June 2026)
- Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018, Galluzzi et al., Cell Death & Differentiation (doi 10.1038/s41418-017-0012-4) (accessed June 2026)
- Guidelines for Regulated Cell Death Assays, Hu et al., Frontiers in Cell and Developmental Biology (doi 10.3389/fcell.2021.634690) (accessed June 2026)
- Ten simple rules for writing a response to reviewers, William Stafford Noble, PLOS Computational Biology (accessed June 2026)
- How to respond to reviewers, Nature Computational Science editorial (accessed June 2026)
Final step
Submitting to Cell Death and Differentiation?
Run the Free Readiness Scan to see score, top issues, and journal-fit signals before you submit.
Target journal carried over: Cell Death and Differentiation
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Same journal, next question
Supporting reads
Conversion step
Submitting to Cell Death and Differentiation?
Anthropic Privacy Partner. Zero-retention manuscript processing.